Temporal Trends of Inflammatory Bowel Disease Burden in China from 1990 to 2030 with Comparisons to Japan, South Korea, the European Union, the United States of America, and the World

References

• Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606–1619. doi:10.1016/S0140-6736(12)60150-0
   PubMed Web of Science ®Google Scholar
• Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741–1755. doi:10.1016/S0140-6736(16)31711-1
   PubMed Web of Science ®Google Scholar
• Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017;44(4):673–692. doi:10.1016/j.pop.2017.07.010
   PubMed Web of Science ®Google Scholar
• Carroll MW, Kuenzig ME, Mack DR, et al. The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD. J Can Assoc Gastroenterol. 2019;2(Suppl 1):S49–S67. doi:10.1093/jcag/gwy056
   PubMedGoogle Scholar
• GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi:10.1016/S2468-1253(19)30333-4
   PubMed Web of Science ®Google Scholar
• Na SY, Moon W. Perspectives on current and novel treatments for inflammatory bowel disease. Gut Liver. 2019;13(6):604–616. doi:10.5009/gnl19019
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12(7):543–550. doi:10.1097/01.MIB.0000225339.91484.fc
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–1605. doi:10.1016/S0140-6736(12)60026-9
   PubMed Web of Science ®Google Scholar
• Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L. Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatol. 2020;18(1):14–23. doi:10.1016/j.cgh.2019.07.005
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105(2):289–297. doi:10.1038/ajg.2009.579
   PubMed Web of Science ®Google Scholar
• Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I. Inflamm Bowel Dis. 2018;24(4):742–751. doi:10.1093/ibd/izx100
   PubMed Web of Science ®Google Scholar
• Shafer LA, Walker JR, Restall G, et al. Association between IBD disability and reduced work productivity (presenteeism): a population-based study in Manitoba, Canada. Inflamm Bowel Dis. 2019;25(2):352–359. doi:10.1093/ibd/izy236
   PubMed Web of Science ®Google Scholar
• Ng SC, Mak JWY, Pal P, Banerjee R. Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol. 2020;5(12):1089–1100. doi:10.1016/S2468-1253(20)30298-3
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• GBD 2019 Diseases and Injuries Collaborator. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1995–2051. doi:10.1016/S0140-6736(18)32278-5
   PubMed Web of Science ®Google Scholar
• GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar
• Yang X, Man J, Chen H, et al. Temporal trends of the lung cancer mortality attributable to smoking from 1990 to 2017: a global, regional and national analysis. Lung Cancer. 2021;152:49–57. doi:10.1016/j.lungcan.2020.12.007
   PubMed Web of Science ®Google Scholar
• Yang X, Fang Y, Chen H, et al. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019. Epidemiol Psychiatr Sci. 2021;30:e36. doi:10.1017/S2045796021000275
   PubMed Web of Science ®Google Scholar
• Yu J, Yang X, He W, Ye W. Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Int J Cancer. 2021;149(5):993–1001. doi:10.1002/ijc.33617
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang T, Zhang H, Sang S, Chen H, Zuo X. Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia. Biomark Res. 2021;9(1):84. doi:10.1186/s40364-021-00340-6
   PubMed Web of Science ®Google Scholar
• Knoll M, Furkel J, Debus J, Abdollahi A, Karch A, Stock C. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20(1):257. doi:10.1186/s12874-020-01133-5
   PubMed Web of Science ®Google Scholar
• Du Z, Chen W, Xia Q, Shi O, Chen Q. Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study. Biomark Res. 2020;8:16. doi:10.1186/s40364-020-00195-3
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao S, Wang S, et al. Global magnitude of encephalitis burden and its evolving pattern over the past 30 years. J Infect. 2022;84(6):777–787. doi:10.1016/j.jinf.2022.04.026
   PubMed Web of Science ®Google Scholar
• Dulai PS, Singh S, Ohno-Machado L, Sandborn WJ. Population health management for inflammatory bowel disease. Gastroenterology. 2018;154(1):37–45. doi:10.1053/j.gastro.2017.09.052
   PubMed Web of Science ®Google Scholar
• Click B, Lopez R, Arrigain S, Schold J, Regueiro M, Rizk M. Shifting cost-drivers of health care expenditures in inflammatory bowel disease. Inflamm Bowel Dis. 2020;26(8):1268–1275. doi:10.1093/ibd/izz256
   PubMed Web of Science ®Google Scholar
• Yao LY, Shao BL, Tian F, et al. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease. World J Gastroenterol. 2022;28(30):4102–4119. doi:10.3748/wjg.v28.i30.4102
   PubMed Web of Science ®Google Scholar
• El-Matary W, Kuenzig ME, Singh H, et al. Disease-associated costs in children with inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2020;26(2):206–215. doi:10.1093/ibd/izz120
   PubMed Web of Science ®Google Scholar
• van der Valk ME, Mangen MJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: results from the COIN study. Gut. 2014;63(1):72–79. doi:10.1136/gutjnl-2012-303376
   PubMed Web of Science ®Google Scholar
• Yu Q, Zhu C, Feng S, et al. Economic burden and health care access for patients with inflammatory bowel diseases in China: web-based survey study. J Med Internet Res. 2021;23(1):e20629. doi:10.2196/20629
   PubMed Web of Science ®Google Scholar
• Luo XP, Mao R, Chen BL, et al. Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease. Patient Prefer Adherence. 2017;11:23–31. doi:10.2147/PPA.S118589
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205–217. doi:10.1038/nrgastro.2015.34
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157(3):647–659 e644. doi:10.1053/j.gastro.2019.04.016
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Vegh Z, Lovasz BD, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis. 2013;19(5):1010–1017. doi:10.1097/MIB.0b013e3182802b3e
   PubMed Web of Science ®Google Scholar
• Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81(11):1462–1471. doi:10.4065/81.11.1462
   PubMed Web of Science ®Google Scholar
• Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107(9):1399–1406. doi:10.1038/ajg.2012.196
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, Bonovas S. Inflammatory bowel disease: estimates from the global burden of disease 2017 study. Aliment Pharmacol Ther. 2020;51(2):261–270. doi:10.1111/apt.15542
   PubMed Web of Science ®Google Scholar
• Word Health Organization. World Health Statistics 2021; 2021. Available from: https://www.who.int/publications/i/item/9789240027053. Accessed April 26, 2023.
   Google Scholar
• Fang EF, Scheibye-Knudsen M, Jahn HJ, et al. A research agenda for aging in China in the 21st century. Ageing Res Rev. 2015;24(Pt B):197–205. doi:10.1016/j.arr.2015.08.003
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Bernstein CN, Bitton A, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112(7):1120–1134. doi:10.1038/ajg.2017.97
   PubMed Web of Science ®Google Scholar
• Agrawal M, Christensen HS, Bogsted M, Colombel JF, Jess T, Allin KH. The rising burden of inflammatory bowel disease in Denmark over two decades: a Nationwide Cohort Study. Gastroenterology. 2022;163(6):1547–1554.e5. doi:10.1053/j.gastro.2022.07.062
   PubMed Web of Science ®Google Scholar
• Faye AS, Colombel JF. Aging and IBD: a new challenge for clinicians and researchers. Inflamm Bowel Dis. 2022;28(1):126–132. doi:10.1093/ibd/izab039
   PubMed Web of Science ®Google Scholar
• Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21(8):40. doi:10.1007/s11894-019-0705-6
   PubMedGoogle Scholar
• Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
   PubMed Web of Science ®Google Scholar
• Zhu H, Ma X, Ye T, et al. Esophageal cancer in China: practice and research in the new era. Int J Cancer. 2022;152:1741–1751. doi:10.1002/ijc.34301
   PubMed Web of Science ®Google Scholar
• Yang W, Zhao R, Chuai X, et al. China’s pathway to a low carbon economy. Carbon Balance Manag. 2019;14(1):14. doi:10.1186/s13021-019-0130-z
   PubMed Web of Science ®Google Scholar
• Peng Z, Wu L. Association of income relative deprivation and sleep duration in China. Front Psychol. 2022;13:1008259. doi:10.3389/fpsyg.2022.1008259
   PubMed Web of Science ®Google Scholar